Wilson Sonsini Goodrich & Rosati advised Inco on the transaction. Inco announced it has raised $4.5 million in a seed funding round, led by 1kx and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati assisted NETGEAR on the case, and Schlam, Stone & Dolan, while Dovel & Luner assisted Network-1 Technologies. On February 20, 2024,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Niron Magnetics on the transaction. Niron Magnetics announced it has raised $25 million in new strategic funding round led by by Samsung...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison is advising General Atlantic Service Company, L.P. and Stone Point Capital on the transaction, Simpson Thacher & Bartlett is advising...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Owner.com in the transaction. Owner.com announced it raised $33 million Series B round to bring the company to a $200 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Neurona Therapeutics on the transaction. Neurona Therapeutics announced it closed a $120 million financing co-led by Viking Global Investors and Cormorant...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Entrust in the transaction, and Wilson Sonsini Goodrich & Rosati represented Onfido. Entrust, a global leader in trusted payments, identities, and data...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ArteraAI on the transaction. ArteraAI announced it has secured an additional $20 million in capital fueled by several prominent large...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Halia Therapeutics in the transaction. Halia Therapeutics announced it raised $30 million in Series C financing round led by Todd Pedersen, with continued...
You must be a Standard 1 Year member to access this content.
